Watching Kineta; Zacks Small-Cap Research Sets $13.50 Price Valuation
Portfolio Pulse from Happy Mohamed
Zacks Small-Cap Research has set a price valuation of $13.50 for Kineta, a biotechnology company focused on developing novel immunotherapies. The valuation is based on the company's pipeline and potential market opportunities.
June 20, 2023 | 1:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zacks Small-Cap Research has set a price valuation of $13.50 for Kineta, indicating potential growth for the company's stock.
The price valuation set by Zacks Small-Cap Research is based on Kineta's pipeline and potential market opportunities. This indicates that the company has a strong potential for growth, which could positively impact its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100